At a glance
ClinicalIndex Comparison Record- ✓At least 18 years of age
- ✓Radical surgery for cutaneous malignant melanoma stage IIb-c or III
- ✓Sufficient renal function for i.v. contrast imaging
- ✕Unfit to receive treatment in case of recurrence
- ✕Life expectancy less than 2 years due to concurrent disease
- ✕Unable to provide informed consent or refusal to consent
- ✕Unable to comply with control or follow-up program
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma
In Brief
A clinical study evaluating CT or PET scans for Malignant Melanoma. Currently recruiting, targeting 1,300 participants across 20 sites.
Signals
Detailed Summary
It is not known whether radiological assessments during follow up after surgery for high risk melanoma improve survival. Since radiological examinations are resource demanding, could inflict worry and cause irradiation exposure it is an important question to address. With the introduction of effective medical treatments for malignant melanoma patients, there is a tendency to introduce radiological assessments despite the lack of evidence.
Study Details
Timeline
Interventions
Scans and blood tests are scheduled at baseline, months 6, 12, 24 and 36.